• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: 'Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors' by Meyer .

作者信息

Rosenzwajg Michelle, Lorenzon Roberta, Klatzmann David

机构信息

AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), F-75013, Paris, France, AP-HP, Paris, France.

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Sorbonne Unversité, Paris, France.

出版信息

Ann Rheum Dis. 2021 Dec;80(12):e197. doi: 10.1136/annrheumdis-2019-216598. Epub 2020 Jan 21.

DOI:10.1136/annrheumdis-2019-216598
PMID:31964656
Abstract
摘要

相似文献

1
Response to: 'Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors' by Meyer .
Ann Rheum Dis. 2021 Dec;80(12):e197. doi: 10.1136/annrheumdis-2019-216598. Epub 2020 Jan 21.
2
Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors.类风湿关节炎患者体内的调节性T细胞频率可通过传统和生物性改善病情抗风湿药升高，但JAK抑制剂无此作用。
Ann Rheum Dis. 2021 Dec;80(12):e196. doi: 10.1136/annrheumdis-2019-216576. Epub 2019 Nov 19.
3
State of the art: approved and emerging JAK inhibitors for rheumatoid arthritis.最新进展：类风湿关节炎获批和新兴 JAK 抑制剂。
Expert Opin Pharmacother. 2021 Feb;22(2):205-218. doi: 10.1080/14656566.2020.1822325. Epub 2020 Sep 23.
4
JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis.JAK-STAT 抑制剂：类风湿关节炎治疗管理的浸入式治疗方法。
Int Immunopharmacol. 2020 Sep;86:106731. doi: 10.1016/j.intimp.2020.106731. Epub 2020 Jun 23.
5
Patients' safety skills assessment with biologics and JAK inhibitors: Update of the BioSecure questionnaire.使用生物制剂和JAK抑制剂对患者安全技能的评估：BioSecure问卷的更新
Joint Bone Spine. 2021 Oct;88(5):105215. doi: 10.1016/j.jbspin.2021.105215. Epub 2021 May 14.
6
[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice with JAK inhibitors.].[类风湿关节炎的诊断与治疗：迈向最佳实践。JAK抑制剂的最佳应用。]
Clin Calcium. 2018;28(5):678-685.
7
Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis.类风湿关节炎患者心血管系统中 Janus 激酶（JAK）抑制剂的临床方面。
Int J Mol Sci. 2020 Oct 7;21(19):7390. doi: 10.3390/ijms21197390.
8
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.EULAR 推荐的类风湿关节炎治疗策略：2019 年更新版（使用合成和生物疾病修正抗风湿药物）
Ann Rheum Dis. 2020 Jun;79(6):685-699. doi: 10.1136/annrheumdis-2019-216655. Epub 2020 Jan 22.
9
Malignancies and rheumatoid arthritis, csDMARDs, biological DMARDs, and JAK inhibitors: challenge and outlook.恶性肿瘤与类风湿关节炎、传统合成改善病情抗风湿药、生物制剂改善病情抗风湿药及JAK抑制剂：挑战与展望
Expert Rev Clin Immunol. 2023 Jul-Dec;19(11):1325-1342. doi: 10.1080/1744666X.2023.2247158. Epub 2023 Aug 14.
10
The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases?JAK抑制剂：它们会给风湿性疾病的治疗带来范式转变吗？
Rheumatology (Oxford). 2019 Feb 1;58(Suppl 1):i1-i3. doi: 10.1093/rheumatology/key280.